机器学习在原发性肝癌术后复发预测中的应用与可解释性进展
Machine Learning in Predicting Postoperative Recurrence of Hepatocellular Carcinoma: Advances in Application and Explainability
DOI: 10.12677/acm.2026.163847, PDF,   
作者: 张芷艳:重庆医科大学研究生院,重庆;杨 慷*:重庆医科大学附属第二医院肝胆外科,重庆
关键词: 肝细胞癌机器学习术后复发预测模型可解释人工智能影像组学Hepatocellular Carcinoma Machine Learning Postoperative Recurrence Predictive Model Explainable Artificial Intelligence Radiomics
摘要: 原发性肝癌(HCC)是世界上常见的恶性肿瘤之一,全球超过半数新发病例都发生在中国,手术切除是目前最主要的根治性治疗手段,但由于其术后复发率居高不下,严重影响患者的长期生存。因此,术后复发风险的精准预测对个体化治疗策略的制定具有至关重要的意义。近年来,随着人工智能的发展,机器学习(Machine learning)技术在肝癌的预后预测中展现出显著优势,其通过多模态数据融合与复杂模型构建显著提升了预测性能。然而,大多数先进机器学习模型具有“黑箱”特性,其决策过程不透明,限制了其在临床实践中的可信度与推广。本文系统综述了机器学习在肝癌术后复发预测中的应用进展,重点分析了基于临床数据、影像组学、病理图像等不同数据源的机器学习预测模型构建方法与性能,并深入探讨了以SHAP (Shapley Additive Explanations)为代表的可解释性技术在提升模型透明度及临床信任度方面的作用。文章进一步总结了当前研究面临的挑战,如数据异质性、模型泛化能力不足、可解释性标准缺失等,并展望了未来发展方向。
Abstract: Primary liver cancer (HCC) is one of the most common malignant tumors worldwide, with more than half of new cases occurring in China. Surgical resection is currently the primary curative treatment, but its high postoperative recurrence rate significantly affects long-term patient survival. Therefore, accurate prediction of postoperative recurrence risk is crucial for developing personalized treatment strategies. In recent years, with the advancement of artificial intelligence, machine learning (ML) technology has demonstrated significant advantages in prognostic prediction for liver cancer, notably enhancing predictive performance through multimodal data fusion and complex model construction. However, most advanced ML models exhibit “black box” characteristics, with opaque decision-making processes that limit their credibility and generalizability in clinical practice. This article systematically reviews the application progress of ML in postoperative recurrence prediction for liver cancer, focusing on the construction methods and performance of ML prediction models based on different data sources such as clinical data, radiomics, and pathological images. It also explores the role of interpretable techniques, represented by SHAP (Shapley Additive Explanations), in improving model transparency and clinical trust. The article further summarizes current research challenges, such as data heterogeneity, insufficient model generalization, and a lack of interpretability standards, and outlines future research directions.
文章引用:张芷艳, 杨慷. 机器学习在原发性肝癌术后复发预测中的应用与可解释性进展[J]. 临床医学进展, 2026, 16(3): 774-780. https://doi.org/10.12677/acm.2026.163847

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Llovet, J.M., Kelley, R.K., Villanueva, A., Singal, A.G., Pikarsky, E., Roayaie, S., et al. (2022) Hepatocellular Carcinoma. Nature Reviews Disease Primers, 7, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[3] Rattan, P., Penrice, D.D. and Simonetto, D.A. (2022) Artificial Intelligence and Machine Learning: What You Always Wanted to Know but Were Afraid to Ask. Gastro Hep Advances, 1, 70-78. [Google Scholar] [CrossRef] [PubMed]
[4] Topol, E.J. (2019) High-Performance Medicine: The Convergence of Human and Artificial Intelligence. Nature Medicine, 25, 44-56. [Google Scholar] [CrossRef] [PubMed]
[5] 吴中立, 罗超, 杨涌. 肝细胞癌患者肝切除术后1个月外周血RBM15 mRNA及血清GDF-15蛋白变化率对术后复发的预测价值[J]. 检验医学与临床, 2026, 23(1): 7-12+19.
[6] 李佳, 胡海燕, 胡巧丽, 等. 老年肝细胞癌患者根治切除术后复发的影响因素及预测模型构建[J]. 中华老年多器官疾病杂志, 2025, 24(10): 774-778.
[7] 钟丘, 刘权焰. 基于倾向性评分匹配的术前炎症指标预测肝细胞癌术后复发[J]. 武汉大学学报(医学版), 2023, 44(6): 744-749.
[8] 刘春龙. 原发性肝细胞癌肝切除术后早期复发危险因素分析及列线图预测模型的建立[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2024.
[9] 张夕. 基于可解释机器学习算法构建肝癌术后复发预测模型的应用[D]: [硕士学位论文]. 太原: 山西医科大学, 2024.
[10] Liu, R., Wu, S., Yu, H.y., Zeng, K., Liang, Z., Li, S., et al. (2023) Prediction Model for Hepatocellular Carcinoma Recurrence after Hepatectomy: Machine Learning-Based Development and Interpretation Study. Heliyon, 9, e22458. [Google Scholar] [CrossRef] [PubMed]
[11] 刘杨军, 刘淑珍, 李鹏, 等. 基于MSCT特征构建肝细胞癌根治性切除术后复发的预测模型[J]. 中国医学物理学杂志, 2026, 43(2): 261-267.
[12] 杨春燕, 魏小琴, 杨琼, 等. 基于多期增强CT影像组学模型预测肝细胞癌切除术后复发的价值[J]. 中国医学影像学杂志, 2025, 33(3): 245-251.
[13] 张孟溦, 范艳芬, 诗涔, 等. 钆塞酸二钠增强MRI深度学习在粗梁-团块型肝细胞癌诊断及术后复发预测的双中心研究[J]. 中国医学影像学杂志, 2026, 34(1): 90-97.
[14] 董致成, 张金标, 邢梦杨, 等. 基于MRI影像组学对肝细胞癌术后复发的预测价值[J]. 中国医学装备, 2025, 22(5): 57-61.
[15] 陈超. 基于CT图像的机器学习在肝癌术后TACE治疗患者预后预测中的应用研究[D]: [硕士学位论文]. 西安: 西安医学院, 2025.
[16] 刘鑫雨. 基于薄层多期增强CT影像组学探索肝癌预后因素并建立肝癌预后模型[D]: [硕士学位论文]. 西安: 中国人民解放军空军军医大学, 2025.
[17] Saito, A., Toyoda, H., Kobayashi, M., Koiwa, Y., Fujii, H., Fujita, K., et al. (2021) Prediction of Early Recurrence of Hepatocellular Carcinoma after Resection Using Digital Pathology Images Assessed by Machine Learning. Modern Pathology, 34, 417-425. [Google Scholar] [CrossRef] [PubMed]
[18] Sun, C., Li, J., Zhang, T., et al. (2025) Spatial Immune Landscape Reveals Prognostic Immune Signatures and a Risk Score for Recurrence of Hepatocellular Carcinoma. Nature, 636, 513-521.
[19] 郑郭群, 郭丽萍, 陈挺, 等. 原发性肝细胞癌术后早期复发预测模型的建立与评价[J]. 浙江临床医学, 2025, 27(6): 844-847+850.
[20] 王兆阳, 张楠. 基于CT影像组学与中医舌象特征构建肝细胞癌根治术后早期复发的Nomogram预测模型[J]. 实用医学杂志, 2025, 41(16): 2590-2596.
[21] Lundberg, S.M., Nair, B., Vavilala, M.S., Horibe, M., Eisses, M.J., Adams, T., et al. (2018) Explainable Machine-Learning Predictions for the Prevention of Hypoxaemia during Surgery. Nature Biomedical Engineering, 2, 749-760. [Google Scholar] [CrossRef] [PubMed]
[22] 王馨瑶. 超声影像组学对肝细胞肝癌微波消融术后早期复发的预测研究[D]: [硕士学位论文]. 延安: 延安大学, 2024.
[23] 赵仁卿, 吴奇新. 基于MRI深度学习预测肝细胞癌微血管侵犯的研究进展[J]. 磁共振成像, 2025, 16(10): 191-195.
[24] U.S. Food and Drug Administration (2021) Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan.
[25] 国家药品监督管理局医疗器械技术审评中心. 人工智能医疗器械注册审查指导原则: 2022年第8号通告[EB/OL].
https://www.cmde.org.cn/flfg/zdyz/zdyzwbk/20220309091014461.html, 2022-03-09.
[26] Slack, D., Hilgard, S., Jia, E., Singh, S. and Lakkaraju, H. (2020) Fooling LIME and Shap: Adversarial Attacks on Post hoc Explanation Methods. Proceedings of the AAAI/ACM Conference on AI, Ethics, and Society, New York, 7-9 February 2020, 180-186. [Google Scholar] [CrossRef
[27] Rudin, C. (2019) Stop Explaining Black Box Machine Learning Models for High Stakes Decisions and Use Interpretable Models Instead. Nature Machine Intelligence, 1, 206-215. [Google Scholar] [CrossRef] [PubMed]
[28] Wachter, S., Mittelstadt, B. and Russell, C. (2017) Counterfactual Explanations without Opening the Black Box: Automated Decisions and the GDPR. Harvard Journal of Law & Technology, 31, 841.
[29] Perez-Lopez, R., Ghaffari Laleh, N., Mahmood, F. and Kather, J.N. (2024) A Guide to Artificial Intelligence for Cancer Researchers. Nature Reviews Cancer, 24, 427-441. [Google Scholar] [CrossRef] [PubMed]